Sevelamer carbonate NDC 70710-2170

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-2170Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-2170Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70710-2170-3	70710217003	30 TABLET, FILM COATED in 1 BOTTLE (70710-2170-3)Marketed from Apr 1, 2026
70710-2170-7	70710217007	180 TABLET, FILM COATED in 1 BOTTLE (70710-2170-7)Marketed from Apr 1, 2026
70710-2170-8	70710217008	270 TABLET, FILM COATED in 1 BOTTLE (70710-2170-8)Marketed from Apr 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sevelamer carbonate
Generic name (nonproprietary): sevelamer carbonate
Active ingredients: Sevelamer carbonate — 800 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219931
Marketing start: Apr 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 70710-2170_c18f24f4-6578-43b0-9dda-6581e7137ffdSPL ID c18f24f4-6578-43b0-9dda-6581e7137ffdSPL set ID 2ccf62c6-dbad-416d-8e02-631795bd7517RxCUI 749206UNII 9YCX42I8IUUPC 0370710217075, 0370710217037, 0370710217082
Pharmacologic class: Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710217003 followed by a unit qualifier and the quantity

Package 70710-2170-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 18, 2026.

Indications (excerpt from the label)

Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Sevelamer carbonate tablets are a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219931

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219931
Product	Strength	Form · route	Labeler	Product NDC
Sevelamer carbonate	Sevelamer carbonate 800 mg/1	Tablet, Film coatedOral	Navinta LLC	68475-010